FITC Anti-CD90 / Thy1 抗体 [F15-42-1]
FITC Anti-CD90 / Thy1 antibody [F15-42-1]
Be the first to review this product! Submit a review
|
(25 Publications)
Mouse Monoclonal CD90 / Thy1 antibody - conjugated to FITC. Suitable for Flow Cyt and reacts with Human samples. Cited in 25 publications. Immunogen corresponding to Synthetic Peptide within Human THY1.
別名を表示する
CD90, Thy-1 membrane glycoprotein, CDw90, Thy-1 antigen, THY1
- Flow Cyt
Unknown
Flow Cytometry - FITC Anti-CD90 / Thy1 antibody [F15-42-1] (AB11155)
ab11155 staining CD90/Thy1 in human HUT78 T cells by Flow Cytometry analysis.
Reactivity data
製品の詳細
出荷温度及び保存条件
製品の状態
精製方法
精製に関する特記事項
バッファー組成
出荷温度
短期保存温度
長期保存温度
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD90 plays a role in cell-cell and cell-matrix interactions contributing to cellular adhesion migration and signal transduction. It functions as part of a complex involving integrins which mediate its interaction with the extracellular matrix. This protein also influences T-cell activation reflecting its importance in immune response regulation. Its presence aids in modulating response to injury and promoting tissue repair due to its association with stem and progenitor cells.
Pathways
CD90 engagement affects focal adhesion and MAPK signaling pathways. It interacts with integrins like αvβ3 and α5β1 influencing cell movement and proliferation processes. CD90 involvement in these pathways allows it to regulate responses important for cell survival and communication within various tissues. These interactions highlight the protein's role in maintaining cellular homeostasis and regulating physiological processes.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (25)
Recent publications for all applications. Explore the full list and refine your search
Cell biochemistry and biophysics 83:1771-1783 PubMed39681812
2024
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 15:455 PubMed39609719
2024
Applications
Unspecified application
Species
Unspecified reactive species
Regenerative therapy 25:35-48 PubMed38058606
2023
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 13:14102 PubMed37644086
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell journal 24:449-457 PubMed36093804
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35806124
2022
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 12:910-928 PubMed34976220
2022
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medicine : eCAM 2021:4836992 PubMed34853599
2021
Applications
Unspecified application
Species
Unspecified reactive species
The journal of gene medicine 23:e3379 PubMed34296780
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 19:194 PubMed34193158
2021
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com